| Added by | mollevi |
|---|---|
| Group name | EquipeNB |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: IRCM, Institut de Recherche en Cancerologie de Montpellier , INSERM U1194, Universite Montpellier , Montpellier, France. OREGA Biotech ; Ecully, France. Laboratoire Immunologie Dermatologie & Oncologie, Institut National de la Sante et de la Recherche Medicale (INSERM U976) , Universite Paris Diderot , Paris, France. IRCM, Institut de Recherche en Cancerologie de Montpellier , INSERM U1194, Universite Montpellier , Montpellier, France ; Departement d'Immunologie; Centre Hospitalier Regional Universitaire de Montpellier et Faculte de Medecine, Universite de Montpellier , Montpellier, France. alt-title: Oncoimmunology number: 5 accession-num: 26155397 |
| Tags | _EndnoteXML import |
| Date Added | 2018/11/14 - 12:04:32 |
| Date Modified | 2018/11/14 - 12:04:32 |
| Parent item | CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression |
Institut de Recherche en Cancérologie de
